(Q43781249)

26 November 2017

title

Can tamoxifen cause a significant mammographic density change in breast parenchyma? (English)

1 reference

26 November 2017

1 reference

Konez O

1

1 reference

26 November 2017

Goyal M

series ordinal

2

1 reference

26 November 2017

Reaven RE

series ordinal

3

1 reference

26 November 2017

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

25

1 reference

26 November 2017

issue

5

1 reference

26 November 2017

page(s)

303-308

1 reference

Estrogen and the postmenopausal breast. Mammographic considerations

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0899-7071%2801%2900329-1

7 January 2021

Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0899-7071%2801%2900329-1

7 January 2021

Hormonal replacement therapy: mammographic manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0899-7071%2801%2900329-1

7 January 2021

Enlarging occult fibroadenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0899-7071%2801%2900329-1

7 January 2021

Tamoxifen in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-7071%2801%2900329-1

7 January 2021

Long term effects of tamoxifen on blood lipid values in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-7071%2801%2900329-1

7 January 2021

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0899-7071%2801%2900329-1

7 January 2021

Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years

1 reference

https://api.crossref.org/works/10.1016%2FS0899-7071%2801%2900329-1

7 January 2021

Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0899-7071%2801%2900329-1

7 January 2021

Can mammographic densities predict effects of tamoxifen on the breast?

1 reference

https://api.crossref.org/works/10.1016%2FS0899-7071%2801%2900329-1

7 January 2021

Regression of breast cancer in four patients treated with tamoxifen: mammographic features

1 reference

https://api.crossref.org/works/10.1016%2FS0899-7071%2801%2900329-1

7 January 2021

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0899-7071%2801%2900329-1

7 January 2021

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0899-7071%2801%2900329-1

7 January 2021

Tamoxifen-induced regression of breast cysts

1 reference

https://api.crossref.org/works/10.1016%2FS0899-7071%2801%2900329-1

7 January 2021

10.1016/S0899-7071(01)00329-1

Identifiers

DOI

1 reference

26 November 2017

1 reference